Keytone Dairy (ASX:KTD) - CEO, Danny Rotman
CEO, Danny Rotman
Source: Keytone Dairy
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Keytone Dairy (KTD) has been awarded a significant Coles Private Label Tender by Coles Supermarkets (COL)
  • Sales are expected to total $5.2 million per year and while the terms have not been specified, the company believes it will be longer than an initial 12-month period
  • Products will be manufactured at Keytone’s Melbourne facilities
  • Production is set to begin late in the first quarter of 2021 and the product is set to be available in Coles stores from Q2 2021
  • Keytone is up 6.12 per cent on the market with shares trading at 26 cents

Keytone Dairy (KTD) has been awarded a significant Coles Private Label Tender by Coles Supermarkets (COL).

The tender process was very competitive and was won as a result of Keytone’s thorough health and safety standards and its manufacturing facilities.

Sales are expected to total $5.2 million per year and the products will be manufactured at Keytone’s Melbourne facilities.

While the term of the tender has not been specified, Keytone believes it will be longer than an initial 12-month period.

Production is set to begin late in the first quarter of 2021 with the product to be available in Coles stores from the following quarter.

“This is a fantastic and significant win for the business. It highlights the growing awareness of the Keytone brand of quality and our credentials across the broader health and wellness sector,” CEO Danny Rotman said.

“This tender win comes shortly after and in addition to the recently announced Foodstuffs contract in New Zealand and significant increases in the sales forecast for Walmart China and Nouriz China, providing Keytone with a growing sales pipeline through the next calendar year and beyond,” he added.

Keytone is up 6.12 per cent on the market with shares trading at 26 cents at 11:29am AEDT.

KTD by the numbers
More From The Market Online

Cettire turbulent on $191M revenue, but no word on customs scandal

Cettire shares spiked upwards right out the gate on Friday on the same day the company…

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms'…

23% profit jump for NZ dairy co-op Fonterra

New Zealand dairy cooperative Fonterra has raised its profits 23 percent to NZ$674 million in the…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…